Sign In

CPG Infobase: Clinical Practice Guidelines


The CPG Infobase is a database of evidence-based Canadian clinical practice guidelines (CPGs). Maintained by Joule, a CMA company, it includes approximately 1,200 CPGs developed or endorsed by authoritative medical or health organizations in Canada.

List of Guidelines

For Subject: Chimiothérapie
Number of CPGs:  103

  • Results 1-10
1.
Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update

View HTML
2018-Oct
Canadian Cardiovascular Harmonized National Guideline Endeavour (C-CHANGE)

Detailed Result

2.
The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the Liver

View PDF
2018-June
Canadian Association for the Study of the Liver

Detailed Result

3.
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder

View PDF
2018-Mar
Canadian Network for Mood and Anxiety Treatments

Detailed Result

4.
An endorsement of the 2017 American Urological Association treatment of non-metastatic bladder cancer: AUA, ASCO, ASTRO, SUO guideline

View PDF
2018-Jan
American Urological Association
American Society for Radiation Oncology
American Society of Clinical Oncology
Society of Urologic Oncology

Detailed Result

5.
Canadian ADHD practice guidelines, 4th Edition

View PDF
2018
Canadian Attention Deficit Hyperactivity Disorder Resource Alliance

Detailed Result

6.
Traitements visant la vessie hyperactive : accent sur la pharmacothérapie – addenda

View HTML
2017-déc
Société des obstétriciens et gynécologues du Canada

Detailed Result

7.
Treatments for overactive bladder: focus on pharmacotherapy - an addendum

View HTML
2017-Dec
Society of Obstetricians and Gynaecologists of Canada

Detailed Result

8.
2017 Comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure

View PDF
2017-Nov
Canadian Cardiovascular Society

Detailed Result

9.
Canadian guidelines for the pharmacological treatment of schizophrenia spectrum and other psychotic disorders in children and youth

View HTML
2017-Sept
Canadian Schizophrenia Guidelines Working Group

Detailed Result

10.
Canadian treatment guidelines for individuals at clinical high risk of psychosis

View HTML
2017-Sept
Canadian Schizophrenia Guidelines Working Group

Detailed Result



Disclaimer:
All content is provided for information and education and not as a substitute for the advice of a physician. Joule assumes no responsibility or liability arising from any error or omission or from the use of any information contained herein.